Key Takeaways
- Completing the NHS’s pathology transformation could unlock £450m annually for workforce and infrastructure improvements.
- The review emphasizes operational management over structural reform to enhance service delivery.
- Significant disparities in performance were noted, with many trusts failing to meet turnaround standards.
Pathology Transformation Review Highlights Challenges and Opportunities
An independent review, ‘The Pathology Transformation Review 2026’, led by Lord Carter of Coles, indicates that completing the NHS’s pathology transformation program could generate approximately £450 million annually. These funds could be directed towards enhancing workforce capacity, digital infrastructure, and quality improvements within the pathology services.
Pathology services currently administer over two billion tests each year, integral to 95% of patient pathways including cancer diagnosis, urgent care, and chronic condition management. The review finds that although pathology services have made advancements since earlier evaluations in 2006 and 2008, inconsistencies in integration and workforce shortages hinder their full potential.
The review does not advocate for additional structural reforms; instead, it calls for completing the implementation of already established pathology service models. This can be achieved with stronger operational management, enhanced data availability, clearer accountability, and continued investment.
Lord Carter of Coles stresses the importance of pathology in modern healthcare: “It supports urgent care, cancer pathways, and long-term condition management, while operating largely out of public view.” He notes the progress made, yet emphasizes that many areas have yet to fulfill necessary operational models for effective integration.
Disparities in service performance across England were a key finding, with fewer than half of healthcare providers meeting acute turnaround standards for blood sciences. Alarmingly, only 2% of trusts are projected to meet the 10-day turnaround target for histopathology by 2025, a drop from 14% in 2020. Additionally, partially integrated services were found to have significantly more open Datix incidents than fully integrated counterparts.
Workforce challenges persist, particularly in cellular pathology, where consultant vacancies remain high. In 2025, around two-thirds of trusts reported utilizing at least one non-accredited test type, indicating areas of concern in quality assurance and accreditation.
Dr. Sarah Pitt, president of the Institute of Biomedical Science (IBMS), noted that the review underscores the pressures faced by pathology services and provides recommendations on workforce, training, and digital competencies. She stated that implementing these recommendations must create better opportunities for staff at all levels, from entry-level roles to advanced practice.
To navigate the next stage of transformation, the report outlines five key priorities:
1. Completing operational integration.
2. Establishing nationally comparable performance data.
3. Strengthening workforce planning and advanced practice.
4. Aligning digital infrastructure with workforce redesign and funding reform.
5. Embedding clear accountability across pathology service models.
These strategies aim to improve effectiveness and efficiency in pathology services, ultimately enhancing patient care across the NHS.
The content above is a summary. For more details, see the source article.
